4//SEC Filing
Rubin Eyal 4
Accession 0001144204-17-060168
CIK 0001137883other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:26 PM ET
Size
8.0 KB
Accession
0001144204-17-060168
Insider Transaction Report
Form 4
Rubin Eyal
CFO and Treasurer
Transactions
- Award
Common Stock
2017-11-20+25,000→ 25,000 total - Award
Stock Option (right to buy)
2017-11-20+93,686→ 93,686 totalExercise: $4.30From: 2018-11-20Exp: 2027-11-20→ Common Stock (93,686 underlying)
Footnotes (2)
- [F1]Shares acquired are shares of restricted stock awarded on November 20, 2017 under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 100% of the award on April 1, 2018, provided that the Reporting Person remains continuously employed by Brainstorm Cell Therapeutics Ltd. from the date of grant through the vesting date.
- [F2]Option shall vest and become exercisable as to 25% of the underlying shares on each of the first, second, third and fourth anniversary of the date of grant, until fully vested and exercisable on the fourth anniversary of the date of grant, provided Reporting Person remains employed by Brainstorm Cell Therapeutics Ltd. from the date of grant through each applicable vesting date.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001721411
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:26 PM ET
- Size
- 8.0 KB